Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP, Pharm, R&D
-
Issuer Symbol
-
JNJ on NYSE
There are no Buy or Sell transactions made by Mathai Mammen since 14 Feb 2025
Holdings reported by Mathai Mammen for JOHNSON & JOHNSON
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
41,934 |
$7,212,648 |
$172.00 |
15 Feb 2022 |
Direct |
|
|
| Employee Stock Options (Right to Buy) |
38,736 |
$2,809,909 |
$72.54 |
14 Feb 2022 |
Direct |
Common Stock |
|
| Restricted Share Units |
3,922 |
$613,126 |
$156.33 |
14 Feb 2022 |
Direct |
Common Stock |
|
| Performance Share Units |
737 |
$116,004 |
$157.40 |
15 Feb 2022 |
Direct |
Common Stock |
|
Transactions reported by Mathai Mammen for JOHNSON & JOHNSON
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.